BINCREDO Trademark

Trademark Overview

On Friday, June 12, 2015, a trademark application was filed for BINCREDO with the United States Patent and Trademark Office. The USPTO has given the BINCREDO trademark a serial number of 86660929. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 10, 2021. This trademark is owned by Novartis AG. The BINCREDO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous, immune, and cardiovascular systems, and for use in oncology; pharmaceutical preparations for the treatment of blood and blood forming organs
bincredo

General Information

Serial Number86660929
Word MarkBINCREDO
Filing DateFriday, June 12, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 10, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 6, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the central nervous, immune, and cardiovascular systems, and for use in oncology; pharmaceutical preparations for the treatment of blood and blood forming organs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 16, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4002
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, May 10, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 10, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, December 18, 2020ASSIGNED TO EXAMINER
Tuesday, October 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 5, 2020EXTENSION 5 GRANTED
Wednesday, September 30, 2020EXTENSION 5 FILED
Monday, October 5, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 30, 2020TEAS EXTENSION RECEIVED
Tuesday, March 31, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, March 29, 2020EXTENSION 4 GRANTED
Sunday, March 29, 2020EXTENSION 4 FILED
Sunday, March 29, 2020TEAS EXTENSION RECEIVED
Tuesday, October 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, September 29, 2019EXTENSION 3 GRANTED
Sunday, September 29, 2019EXTENSION 3 FILED
Sunday, September 29, 2019TEAS EXTENSION RECEIVED
Wednesday, April 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 1, 2019EXTENSION 2 GRANTED
Monday, April 1, 2019EXTENSION 2 FILED
Monday, April 1, 2019TEAS EXTENSION RECEIVED
Tuesday, October 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, September 30, 2018EXTENSION 1 GRANTED
Sunday, September 30, 2018EXTENSION 1 FILED
Sunday, September 30, 2018TEAS EXTENSION RECEIVED
Tuesday, April 3, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 6, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 17, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 3, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 3, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, January 3, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 3, 2018EXAMINERS AMENDMENT E-MAILED
Wednesday, January 3, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, November 20, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, November 20, 2017FINAL REFUSAL E-MAILED
Monday, November 20, 2017FINAL REFUSAL WRITTEN
Friday, October 27, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 27, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 27, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 24, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 24, 2017NON-FINAL ACTION E-MAILED
Wednesday, May 24, 2017NON-FINAL ACTION WRITTEN
Tuesday, May 16, 2017LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, November 14, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, May 10, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, May 10, 2016ASSIGNED TO LIE
Friday, November 6, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, November 6, 2015LETTER OF SUSPENSION E-MAILED
Friday, November 6, 2015SUSPENSION LETTER WRITTEN
Monday, October 19, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 19, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 19, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 21, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 21, 2015NON-FINAL ACTION E-MAILED
Monday, September 21, 2015NON-FINAL ACTION WRITTEN
Wednesday, September 16, 2015ASSIGNED TO EXAMINER
Tuesday, June 16, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, June 16, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

bincredo pharmaceutical blood treatment preparations oncology organs systems forming nervous diseases